Cargando…
Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform
Despite the improvements in the management of hypertension during the last three decades, it continues to be one of the leading causes of cardiovascular morbidity and mortality worldwide. Effective and sustained reductions in blood pressure (BP) reduce the incidence of myocardial infarction, stroke,...
Autores principales: | Volpe, Massimo, Tocci, Giuliano, de la Sierra, Alejandro, Kreutz, Reinhold, Laurent, Stéphane, Manolis, Athanasios J., Tsioufis, Kostantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681620/ https://www.ncbi.nlm.nih.gov/pubmed/29086364 http://dx.doi.org/10.1007/s40292-017-0239-7 |
Ejemplares similares
-
Telemedicine and Digital Medicine in the Clinical Management of Hypertension and Hypertension-Related Cardiovascular Diseases: A Position Paper of the Italian Society of Arterial Hypertension (SIIA)
por: Minuz, Pietro, et al.
Publicado: (2023) -
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension
por: Mancusi, Costantino, et al.
Publicado: (2021) -
Olmesartan medoxomil for the treatment of hypertension in children and adolescents
por: Tocci, Giuliano, et al.
Publicado: (2011) -
Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature
por: Tsioufis, Konstantinos, et al.
Publicado: (2020) -
Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper
por: Golubnitschaja, Olga, et al.
Publicado: (2014)